AstraZeneca PLC (AZN)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	231,421	203,171	209,268	209,442	182,034	131,259
Market Cap Growth	-11.19%	-2.91%	-0.08%	15.06%	38.68%	-0.69%
Enterprise Value	256,587	228,175	234,801	238,391	209,520	149,836
Last Close Price	74.59	64.61	65.04	64.15	53.86	45.01
PE Ratio	14.03	28.88	35.14	63.70	1625.31	41.07
PS Ratio	4.10	3.76	4.57	4.72	4.87	4.93
PB Ratio	5.16	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	20.71	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	17.28	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	4.54	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	13.41	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	17.88	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	22.96	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.74	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.69	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.95	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.52	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.65	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.66	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.86	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	19.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	8.28%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Capital (ROIC)	11.88%	11.53%	8.80%	7.82%	3.26%	7.45%
Return on Capital Employed (ROCE)	18.20%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.58%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.83%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	2.06%	4.80%	4.46%	4.52%	5.33%	6.22%
Payout Ratio	28.92%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	-0.06%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	2.00%	4.73%	4.33%	-4.80%	-3.35%	5.30%

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q